Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Neurodegeneration

Volumn 5, Issue 3, 1996, Pages 265-274

  McNaught, Kevin St P ^a   Thull, Ulrike ^b   Carrupt, Pierre Alain ^b   Altomare, Cosimo ^c   Cellamare, Saverio ^c   Carotti, Angelo ^c   Testa, Bernard ^b   Jenner, Peter ^a   Marsden, C David ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF BARI   (Italy)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

1,2,3,4 tetrahydroisoquinoline; 1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine 1 methyl 4 phenylpyridinium; Isoquinoline derivatives; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 6,7 DIMETHOXY 1 STYRYL 3,4 DIHYDROISOQUINOLINE; AMPHETAMINE; APOMORPHINE; DOPAMINE; HOMOVANILLIC ACID; ISOQUINOLINE DERIVATIVE; N METHYL 6,7 DIMETHOXYISOQUINOLINIUM; N,N PROPYLISOQUINOLINE; NEUROTOXIN; TETRAHYDROISOQUINOLINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CELL COUNT; CELL DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; MALE; MOTOR ACTIVITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ROTATION; STRUCTURE ACTIVITY RELATION; SUBSTANTIA NIGRA;

EID: 0030249938     PISSN: 10558330     EISSN: None     Source Type: Journal    
DOI: 10.1006/neur.1996.0035     Document Type: Article

References (49)

1. +. Neurosci Lett 100:306-312
2. Bradbury AJ, Costall B, Domeney AM, Jenner P, Kelly ME, Marsden CD, Naylor RJ (1986) 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway. Nature 319:56-57
3. Cleeter MJW, Cooper JM, Schapira AHV (1992) Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium-evidence for free radical involvement. J Neurochem 58:786-789
4. Deitrich R, Erwin V (1980) Biogenic amine-aldehyde condensation products: tetrahydroisoquinolines and tryptolines (β-carbolines). Annu Rev Pharmacol Toxicol 20:55-80
5. Denton T, Howard BD (1987) A dopaminergic cell line variant resistant to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J Neurochem 49:622-630
6. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Jenner P, Marsden CD (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114:1953-1975
7. Dexter DT, Holley AE, Flitter WD, Slater TF, Wells RF, Daniel SE, Lees AJ, Jenner P, Marsden CD (1994) Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study. Mov Disord 9:92-97
8. +(1-methyl-4-phenylpyridinium) in rat and mouse. Brain Res 461:361-366
9. Irwin I, Langston JW (1993) MPTP and Parkinson's disease. In: Harvey AL (ed), Natural and Synthetic Neurotoxins, Academic Press, pp 225-256
10. Jenner P (1993) Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease. Acta Neurol Scand 87 (suppl 146):6-13
11. +) analogs: in vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake. Eur J Pharmacol 166:65-74
12. Kikuchi K, Nagatsu Y, Makino Y, Mashino T, Ohta S, Hirobe M (1991) Metabolism and penetration through the blood-brain barrier of parkinsonism-related compounds: 1,2,3,4-tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline. Drug Metab Dispos 19:257-262
13. Konigsmark BW (1970) Methods for the counting of neurons. In Nauta WJH, Ebbesson SOE (eds), Contemporary Research Methods in Neuroanatomy. Springer, New York, pp. 315-340
14. Maruyama W, Dostert P, Matsubara K, Naoi M (1995b) N-methyl(R)salsolinol produces hydroxyl radicals: involvement to neurotoxicity. Free Rad Biol Med 19:67-75
15. Maruyama W, Dostert W, Naoi M (1995a) Dopamine-derived 1-methyl-6,7-dihydroxyisoquinoline as hydroxyl radical promoters and scavengers: In vivo and in vitro studies. J Neurochem 64:2635-2643
16. Maruyama W, Nakahara D, Ota M, Takahashi T, Takahashi A, Nagatsu T, Naoi M (1992) N-Methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: In vivo microdialysis study. J Neurochem 59:395-400
17. Maruyama W, Takahashi T, Minami M, Takahashi A, Dostert P, Nagatsu T, Naoi M (1993) Cytotoxicity of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, in Narabayashi H, Nagatsu T, Yanagisawa N, Mizuno Y (eds), Advances in Neurology, Vol. 60. Raven Press Ltd., New York pp 224-230
18. McNaught KSt.P, Thull U, Carrupt PA, Altomare C, Cellamare S, Carotti A, Testa B, Jenner P, Marsden CD (1995a) Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Biochem Pharmacol 50:1903-1911
19. McNaught KSt.P, Altomare C, Cellamare S, Carotti A, Thull U, Carrupt PA, Testa B, Jenner P, Marsden CD (1995b) Inhibition of α-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Neuroreport 6:1105-1108
20. McNaught KSt.P, Thull U, Carrupt PA, Altomare C, Cellamare S, Carotti A, Testa B, Jenner P, Marsden CD (1996a) Effects of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on mitochondrial respiration. Biochem Pharmacol 51:1503-1511
21. 3H] dopamine into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Biochem Pharmacol 52:29-34
22. McNaught KSt.P, Thull U, Carrupt PA, Altomare C, Cellamare S, Carotti A, Testa B, Jenner P, Marsden CD (1996c) Toxicity to PC12 cells of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurosci Lett 206:37-40
23. Mizuno Y, Matuda S, Yoshino H, Mori H, Hattori N, Ikebe S (1994) A immunohistochemical study on α-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann Neurol 35:204-210
24. Mizuno Y, Saitoh T, Sone N (1987) Inhibition of mitochondrial α-ketoglutarate dehydrogenase by 1-methyl-4-phenylpyridinium ion. Biochem Biophys Res Commun 143:971-976
25. Nagatsu T, Yoshida M (1987) An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions. Neurosci Lett 87:178-182
26. Naoi M, Matsurra S, Parvez H, Takahashi T, Hirata Y, Minami M, Nagatsu T (1989a) Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase. J Neurochem 52:653-655
27. Naoi M, Matsuura S, Takahashi T, Nagatsu T (1989b) A N-methyl-transferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neutrotoxin, N-methylisoquinolinium ion. Biochem Biophys Res Commun 161:1213-1219
28. Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridinium, a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci 36:2503-2508
29. +) destroys cultured mesencephalic dopamine neurons. Biogenic Amines 8:61-67
30. +) and tetrahydroisoquinoline derivatives on dopaminergic neurons in ventral mesencephalic striatal co-culture. Neurodegeneration 3:33-42
31. Niwa T, Takeda N, Sasaoka T, Kaneda N, Hashizume Y, Yoshizumi H, Tatematsu A, Nagatsu T (1989) Detection of tetrahydroisoquinoline in parkinsonism as an endogenous amine by use of gas-chromatography-mass spectrometry. J Chromatogr 491:397-403
32. Niwa T, Takeda N, Tatematsu A, Matsuura S, Yoshida M, Nagatsu T (1988) Migration of tetrahydroisoquinoline, a possible parkinsonian neurotoxin, into monkey brain from blood as proved by gas chromatography-mass spectrometry. J Chromatogr 452:85-91
33. Ogawa M, Araki M, Nagatsu I, Nagatsu T, Yoshida M (1989) The effects of 1,2,3,4-tetrahydroisoquinolines (TIQ) on mesencephalic dopaminergic neurones in C57BL/6J mice: Immunohistochemical studies-tyrosine hydroxylase. Biogenic Amines 6:427-436
34. Origitano T, Hannigan J, Collins MA (1981) Rat brain salsolinol and blood-brain barrier. Brain Res 224:446-451
35. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Academic Press Inc. USA
36. Perry TL, Jones K, Hansen S (1988) Tetrahydroisoquinoline lacks dopaminergic nigrostriatal neurotoxicity in mice. Neurosci Lett 85:101-104
37. Ramsay RR, Singer TP (1986) Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria. J Biol Chem 261:7585-7587
38. Saggu H, Cooksey J, Dexter D, Wells FR, Lees A, Jenner P, Marsden CD (1989) A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 53:692-697
39. Sanchez-Ramos JR, Overvik E, Ames BN (1994) A marker of oxyradical-mediated DNA damage (8-hydroxy-2′-deoxyguanosine) is increased in the nigro-striatum in Parkinson's disease brain. Neurodegeneration 3:197-204
40. Saporito M, Heikkila RE, Youngster SK, Nicklas WJ, Geller HM (1992) Dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium analogs in cultured neurons: relationship to the dopamine uptake system and inhibition of mitochondrial respiration. J Pharmacol Exper Therapeut 260:1400-1409
41. Sayre LM, Wang F, Arora PK, Riachi NJ, Harik SI, Hoppel CL (1991) Dopaminergic neurotoxicity in vivo and inhibition of mitochondrial respiration in vitro by possible endogenous pyridinium-like substances. J Neurochem 57:2106-2115
42. 1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 55:2142-2145.
43. Sian J, Dexter DT, Lees AJ, Daniel S, Agid Y, Javoy-Agid F, Jenner P, Marsden CD (1994) Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol 36:348-355
44. + into the nigrostriatal dopamine pathway-I. Behavioural, neurochemical and histological characterization of the lesion. Neuroscience 27:117-128
45. Suzuki K, Mizuno Y, Yasuhiro Y, Nagatsu T, Mitsuo Y (1992) Selective inhibition of complex I by N-methylisoquinolinium ion and N-methyl-1,2,3,4-tetrahydroisoquinoline in isolated mitochondria prepared from mouse brain. J Neurol Sci 109:219-223
46. Suzuki K, Mizuno Y, Yoshida M (1989) Selective inhibition of complex I of the brain electron transport system by tetrahydroisoquinoline. Biochem Biophys Res Commun 162:1541-1545
47. Suzuki K, Mizuno Y, Yoshida M (1990) Inhibition of mitochondrial respiration by 1,2,3,4-tetrahydroisoquinoline-like endogenous alkaloids in mouse brain. Neurochem Res 7:705-710
48. Yoshida M, Niwa T, Nagatsu T (1990) Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioural and biochemical changes. Neurosci Lett 119:109-113
49. Yoshida M, Ogawa M, Suzuki K, Nagatsu T (1993) Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues. In Narabayashi H, Yanagisawa, Mizuno Y (eds), Advances in Neurology, Vol. 60. Raven Press Ltd., New York, pp 207-211